サマリー

静脈内投与ソリューションの世界市場 2023-2027 年
Technavioは、静脈内IVソリューション市場を監視しており、2022年から2027年の間に4011.34百万米ドルで成長し、予測期間中にCAGR 7.11%で加速すると予測しています。当レポートでは、静脈内IVソリューション市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、慢性疾患の有病率の増加、老年人口の増加、非経口栄養剤の需要の増加によって牽引されています。
Technavioの静脈内輸液市場は以下のように区分されます：
タイプ別
- 部分的非経口栄養
- 完全非経口栄養法（Total parenteral nutrition
販売チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別
- アジア
- 北アメリカ
- ヨーロッパ
- その他の地域(ROW)
本調査では、今後数年間における静脈内IVソリューション市場の成長を促進する主な理由の一つとして、静脈内IVソリューションの技術的進歩を挙げています。また、在宅医療の需要の増加や医療分野への投資の拡大が、市場の大きな需要につながるとしています。
Technavioは、複数の情報源からのデータを、主要パラメータの分析によって調査、合成、総括することで、市場の詳細な姿を提示します。当レポートでは、静脈内IVソリューション市場について、以下の分野を取り上げています：
- 静脈内IVソリューションの市場サイジング
- 静脈内IVソリューションの市場予測
- 静脈内IVソリューション市場の産業分析
Technavioの強固なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、静脈内ivソリューション市場の主要ベンダー数社の詳細な分析を提供します：Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc, Fresenius SE and Co.KGaA、Grifols SA、ICU Medical Inc.、JW Pharmaceutical Corp.、Lxir Medilabs Pvt.Ltd. 、MITS Healthcare Pvt.Ltd. 、Pfizer Inc. 、Salius Pharma Pvt.Ltd. 、シュビッツバイオテック、Sichuan Kelun Pharmaceutical Co.Ltd.、Soxa Formulations and Research Pvt. Ltd.、Terumo Group、Vifor Pharma Management Ltd.、Vikrant Life Sciences Pvt. Ltd.、Vitapure Corp.、 B. Braun Melsungen AG、Otsuka Holdings Co.Ltd.、Vitapure Corp.また、静脈内ivソリューション市場分析レポートには、市場成長に影響を与える今後の動向と課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - https://www.technavio.com/report/intravenous-iv-solutions-market-analysis
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。業界の主要なインフルエンサーを特定することにより、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global intravenous (IV) solutions market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Partial parenteral nutrition - Market size and forecast 2022-2027
o Exhibit 34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
o 6.4 Total parenteral nutrition - Market size and forecast 2022-2027
o Exhibit 38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy - Market size and forecast 2022-2027
o Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacy - Market size and forecast 2022-2027
o Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2022-2027
o Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Amanta Healthcare Ltd.
o Exhibit 111: Amanta Healthcare Ltd. - Overview
o Exhibit 112: Amanta Healthcare Ltd. - Product / Service
o Exhibit 113: Amanta Healthcare Ltd. - Key offerings
o 12.4 Axa Parenterals Ltd.
o Exhibit 114: Axa Parenterals Ltd. - Overview
o Exhibit 115: Axa Parenterals Ltd. - Product / Service
o Exhibit 116: Axa Parenterals Ltd. - Key offerings
o 12.5 B. Braun Melsungen AG
o Exhibit 117: B. Braun Melsungen AG - Overview
o Exhibit 118: B. Braun Melsungen AG - Business segments
o Exhibit 119: B. Braun Melsungen AG - Key news
o Exhibit 120: B. Braun Melsungen AG - Key offerings
o Exhibit 121: B. Braun Melsungen AG - Segment focus
o 12.6 Baxter International Inc.
o Exhibit 122: Baxter International Inc. - Overview
o Exhibit 123: Baxter International Inc. - Business segments
o Exhibit 124: Baxter International Inc. - Key news
o Exhibit 125: Baxter International Inc. - Key offerings
o Exhibit 126: Baxter International Inc. - Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 127: Fresenius SE and Co. KGaA - Overview
o Exhibit 128: Fresenius SE and Co. KGaA - Business segments
o Exhibit 129: Fresenius SE and Co. KGaA - Key news
o Exhibit 130: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 131: Fresenius SE and Co. KGaA - Segment focus
o 12.8 Grifols SA
o Exhibit 132: Grifols SA - Overview
o Exhibit 133: Grifols SA - Business segments
o Exhibit 134: Grifols SA - Key offerings
o Exhibit 135: Grifols SA - Segment focus
o 12.9 ICU Medical Inc.
o Exhibit 136: ICU Medical Inc. - Overview
o Exhibit 137: ICU Medical Inc. - Product / Service
o Exhibit 138: ICU Medical Inc. - Key offerings
o 12.10 JW Pharmaceutical Corp.
o Exhibit 139: JW Pharmaceutical Corp. - Overview
o Exhibit 140: JW Pharmaceutical Corp. - Product / Service
o Exhibit 141: JW Pharmaceutical Corp. - Key offerings
o 12.11 Otsuka Holdings Co. Ltd.
o Exhibit 142: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus
o 12.12 Pfizer Inc.
o Exhibit 146: Pfizer Inc. - Overview
o Exhibit 147: Pfizer Inc. - Product / Service
o Exhibit 148: Pfizer Inc. - Key news
o Exhibit 149: Pfizer Inc. - Key offerings
o 12.13 Salius Pharma Pvt. Ltd.
o Exhibit 150: Salius Pharma Pvt. Ltd. - Overview
o Exhibit 151: Salius Pharma Pvt. Ltd. - Product / Service
o Exhibit 152: Salius Pharma Pvt. Ltd. - Key offerings
o 12.14 Sichuan Kelun Pharmaceutical Co. Ltd.
o Exhibit 153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
o Exhibit 154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
o 12.15 Soxa Formulations and Research Pvt. Ltd.
o Exhibit 156: Soxa Formulations and Research Pvt. Ltd. - Overview
o Exhibit 157: Soxa Formulations and Research Pvt. Ltd. - Product / Service
o Exhibit 158: Soxa Formulations and Research Pvt. Ltd. - Key offerings
o 12.16 Terumo Group
o Exhibit 159: Terumo Group - Overview
o Exhibit 160: Terumo Group - Business segments
o Exhibit 161: Terumo Group - Key news
o Exhibit 162: Terumo Group - Key offerings
o Exhibit 163: Terumo Group - Segment focus
o 12.17 Vifor Pharma Management Ltd.
o Exhibit 164: Vifor Pharma Management Ltd. - Overview
o Exhibit 165: Vifor Pharma Management Ltd. - Product / Service
o Exhibit 166: Vifor Pharma Management Ltd. - Key news
o Exhibit 167: Vifor Pharma Management Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Amanta Healthcare Ltd. - Overview
Exhibits112: Amanta Healthcare Ltd. - Product / Service
Exhibits113: Amanta Healthcare Ltd. - Key offerings
Exhibits114: Axa Parenterals Ltd. - Overview
Exhibits115: Axa Parenterals Ltd. - Product / Service
Exhibits116: Axa Parenterals Ltd. - Key offerings
Exhibits117: B. Braun Melsungen AG - Overview
Exhibits118: B. Braun Melsungen AG - Business segments
Exhibits119: B. Braun Melsungen AG - Key news
Exhibits120: B. Braun Melsungen AG - Key offerings
Exhibits121: B. Braun Melsungen AG - Segment focus
Exhibits122: Baxter International Inc. - Overview
Exhibits123: Baxter International Inc. - Business segments
Exhibits124: Baxter International Inc. - Key news
Exhibits125: Baxter International Inc. - Key offerings
Exhibits126: Baxter International Inc. - Segment focus
Exhibits127: Fresenius SE and Co. KGaA - Overview
Exhibits128: Fresenius SE and Co. KGaA - Business segments
Exhibits129: Fresenius SE and Co. KGaA - Key news
Exhibits130: Fresenius SE and Co. KGaA - Key offerings
Exhibits131: Fresenius SE and Co. KGaA - Segment focus
Exhibits132: Grifols SA - Overview
Exhibits133: Grifols SA - Business segments
Exhibits134: Grifols SA - Key offerings
Exhibits135: Grifols SA - Segment focus
Exhibits136: ICU Medical Inc. - Overview
Exhibits137: ICU Medical Inc. - Product / Service
Exhibits138: ICU Medical Inc. - Key offerings
Exhibits139: JW Pharmaceutical Corp. - Overview
Exhibits140: JW Pharmaceutical Corp. - Product / Service
Exhibits141: JW Pharmaceutical Corp. - Key offerings
Exhibits142: Otsuka Holdings Co. Ltd. - Overview
Exhibits143: Otsuka Holdings Co. Ltd. - Business segments
Exhibits144: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits145: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits146: Pfizer Inc. - Overview
Exhibits147: Pfizer Inc. - Product / Service
Exhibits148: Pfizer Inc. - Key news
Exhibits149: Pfizer Inc. - Key offerings
Exhibits150: Salius Pharma Pvt. Ltd. - Overview
Exhibits151: Salius Pharma Pvt. Ltd. - Product / Service
Exhibits152: Salius Pharma Pvt. Ltd. - Key offerings
Exhibits153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
Exhibits154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
Exhibits155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
Exhibits156: Soxa Formulations and Research Pvt. Ltd. - Overview
Exhibits157: Soxa Formulations and Research Pvt. Ltd. - Product / Service
Exhibits158: Soxa Formulations and Research Pvt. Ltd. - Key offerings
Exhibits159: Terumo Group - Overview
Exhibits160: Terumo Group - Business segments
Exhibits161: Terumo Group - Key news
Exhibits162: Terumo Group - Key offerings
Exhibits163: Terumo Group - Segment focus
Exhibits164: Vifor Pharma Management Ltd. - Overview
Exhibits165: Vifor Pharma Management Ltd. - Product / Service
Exhibits166: Vifor Pharma Management Ltd. - Key news
Exhibits167: Vifor Pharma Management Ltd. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations